Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Breast Cancer × capivasertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 17 Prostatic Neoplasms 6 Triple Negative Breast Neoplasms 5 Neoplasm Metastasis 4 Recurrence 2 Ovarian Neoplasms 2 Neoplasms 2 Melanoma 2 Leukemia 2 Healthy Participants 2 Endometrial Neoplasms 2 Disease Progression 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumour 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Non-small Cell Lung Cancer Metastatic 1 Moderate Hepatic Impairment 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Meningioma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematologic Neoplasms 1

Interventions

Fulvestrant 17 Letrozole 7 Capecitabine 5 Anastrozole 5 olaparib 4 Docetaxel 4 pyrotinib 3 palbociclib 3 Paclitaxel 3 Goserelin 3 sacituzumab govitecan 2 exemestane 2 eribulin 2 Vinorelbine 2 Trastuzumab 2 FCN-437c 2 Dasatinib 2 Aromatase Inhibitors 2 Alpelisib 2 Albumin-Bound Paclitaxel 2 vandetanib 1 trastuzumab deruxtecan 1 talazoparib 1 sonidegib 1 ribociclib 1 neratinib 1 liposomal doxorubicin 1 irinotecan sucrosofate 1 entinostat 1 elacestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03182634 2019-01-22

plasmaMATCH

Institute of Cancer Research, United Kingdom

Phase 2 Unknown

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡